Diagnostic Criteria for Diabetic Ketoacidosis (DKA)
The American Diabetes Association requires all three components to be present simultaneously for DKA diagnosis: blood glucose >250 mg/dL, venous pH <7.3, and serum bicarbonate <15 mEq/L, with elevated blood ketones (preferably β-hydroxybutyrate). 1, 2
Core Diagnostic Parameters
The diagnosis of DKA mandates the simultaneous presence of three key elements 2:
- Hyperglycemia: Blood glucose >250 mg/dL, though this threshold is increasingly de-emphasized due to euglycemic DKA (particularly with SGLT2 inhibitors) 2, 3
- Metabolic acidosis: Venous pH <7.3 AND serum bicarbonate <15 mEq/L 1, 2
- Ketosis: Elevated blood β-hydroxybutyrate (β-OHB), which is the gold standard measurement 1, 2, 3
Essential Laboratory Workup
Upon presentation with suspected DKA, immediately obtain 1, 2:
- Complete metabolic panel including sodium, potassium, chloride, bicarbonate, BUN, creatinine, and glucose 2
- Venous blood gas with pH, pCO2, and bicarbonate 2
- Blood β-hydroxybutyrate (NOT urine ketones or nitroprusside tests) 1, 2, 3
- Complete blood count with differential 2
- Urinalysis 2
- Serum osmolality 2
- Electrocardiogram 2
- Anion gap calculation: [Na⁺] - ([Cl⁻] + [HCO₃⁻]), which should be >10-12 mEq/L in DKA 1, 2
- Bacterial cultures (urine, blood, throat) if infection is suspected 1
Severity Classification
DKA severity determines monitoring intensity and prognosis 1, 2:
Mild DKA
- Venous pH: 7.25-7.30 1, 2
- Bicarbonate: 15-18 mEq/L 1, 2
- Anion gap: >10 mEq/L 2
- Mental status: Alert 1, 2
Moderate DKA
- Venous pH: 7.00-7.24 1, 2
- Bicarbonate: 10-15 mEq/L 1, 2
- Anion gap: >12 mEq/L 2
- Mental status: Drowsy/lethargic 1, 2
Severe DKA
- Venous pH: <7.00 1, 2
- Bicarbonate: <10 mEq/L 1, 2
- Anion gap: >12 mEq/L 2
- Mental status: Stuporous or comatose 1, 2
- Associated with higher morbidity and mortality, often requiring intensive monitoring including central venous and intra-arterial pressure monitoring 1
Critical Ketone Measurement Considerations
Direct blood β-hydroxybutyrate (β-OHB) measurement is mandatory—do NOT rely on urine ketones or nitroprusside-based tests. 1, 2, 3
The nitroprusside method has critical limitations 1, 2:
- Only measures acetoacetate and acetone, completely missing β-OHB (the predominant and strongest ketoacid in DKA) 1, 2
- During treatment, β-OHB converts to acetoacetate, paradoxically making nitroprusside tests appear worse even as the patient improves 1
- Can be falsely negative early in DKA 3
Special Diagnostic Considerations
Euglycemic DKA
- Increasingly common, particularly with SGLT2 inhibitors 2, 3
- Do not dismiss DKA possibility when glucose is <250 mg/dL 3
- All other diagnostic criteria (pH, bicarbonate, ketones) must still be met 2
Diabetic Ketoalkalosis
- DKA can present with pH >7.4 due to concurrent metabolic alkalosis and/or respiratory alkalosis 4
- Increased anion gap metabolic acidosis is still present in all cases 4
- 34% of these cases have severe ketoacidosis (β-OHB ≥3 mmol/L) requiring the same treatment as traditional DKA 4
Type 2 Diabetes
- Use identical diagnostic criteria as type 1 diabetes 3
- DKA is less common but can occur, especially with SGLT2 inhibitors 3
Differential Diagnosis
DKA must be distinguished from 2:
- Lactic acidosis: Measure blood lactate 2
- Toxic ingestions: Salicylate, methanol, ethylene glycol—obtain specific laboratory tests 2
- Chronic renal failure: Assess renal function 1
- Alcoholic ketoacidosis: Clinical history and glucose levels typically lower 1
- Starvation ketosis: Bicarbonate levels typically higher 1
Monitoring During Treatment
Draw blood every 2-4 hours to measure 1, 2:
- Electrolytes (sodium, potassium, chloride) 1
- Glucose 1
- Venous pH 1
- β-hydroxybutyrate 1
- Anion gap 1
- BUN/creatinine 1
- Serum osmolality 1
After initial diagnosis, venous pH and anion gap adequately monitor acidosis resolution—repeated arterial blood gases are unnecessary. 1
Resolution Criteria
DKA is resolved when ALL of the following are met 1, 2:
Ketonemia typically takes longer to clear than hyperglycemia—continue monitoring and insulin therapy even after glucose normalizes. 1, 2
Common Diagnostic Pitfalls to Avoid
- Never rely solely on urine ketones for diagnosis or monitoring, as they miss β-OHB and provide misleading information during treatment 1, 3
- Do not dismiss DKA when glucose is <250 mg/dL, especially in patients on SGLT2 inhibitors 3
- Avoid repeating arterial blood gases unnecessarily after initial diagnosis—venous pH suffices for monitoring 1
- Do not stop monitoring ketones when glucose normalizes, as ketoacidosis resolution lags behind glycemic correction 1, 2